Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Helmut, Brath"'
Publikováno v:
Wiener klinische Wochenschrift. 135:84-90
Autor:
Martin Clodi, Heidemarie Abrahamian, Helmut Brath, Guntram Schernthaner, Johann Brix, Bernhard Ludvik, Heinz Drexel, Christoph H. Saely, Peter Fasching, Gersina Rega-Kaun, Bernhard Föger, Claudia Francesconi, Elke Fröhlich-Reiterer, Alexandra Kautzky-Willer, Jürgen Harreiter, Anton Luger, Michael Resl, Michaela Riedl, Yvonne Winhofer, Sabine E. Hofer, Friedrich Hoppichler, Joakim Huber, Susanne Kaser, Claudia Ress, Monika Lechleitner, Felix Aberer, Julia K. Mader, Harald Sourij, Hermann Toplak, Bernhard Paulweber, Lars Stechemesser, Thomas Pieber, Rudolf Prager, Harald Stingl, Thomas Stulnig, Birgit Rami-Merhar, Michael Roden, Christian Schelkshorn, Thomas C. Wascher, Raimund Weitgasser, Sandra Zlamal-Fortunat
Publikováno v:
Wiener klinische Wochenschrift. 135:32-44
ZusammenfassungDie Hyperglykämie ist wesentlich an der Entstehung der Spätkomplikationen bei an Diabetes mellitus Typ 2 erkrankten Patienten/Patientinnen beteiligt. Während Lebensstilmaßnahmen die Eckpfeiler jeder Diabetestherapie bleiben, benöt
Autor:
Susanne Kaser, Sabine E. Hofer, Lili Kazemi-Shirazi, Andreas Festa, Yvonne Winhofer, Harald Sourij, Helmut Brath, Michaela Riedl, Michael Resl, Martin Clodi, Thomas Stulnig, Claudia Ress, Anton Luger
Publikováno v:
Wiener klinische Wochenschrift. 135:18-31
ZusammenfassungDie unter der Kategorie „andere spezifische Diabetesformen“ zusammengefassten Störungen des Glukosestoffwechsels stellen pathophysiologisch und therapeutisch eine sehr heterogene Krankheitsgruppe dar. Umfasst werden Diabetesformen
Autor:
Alexandra Kautzky-Willer, Helmut Brath
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Externí odkaz:
https://doaj.org/article/09285636571e461aa6593992d8dd398e
Autor:
Sazan Rasul, Barbara Katharina Geist, Helmut Brath, Pascal Baltzer, Lalith Kumar Shiyam Sundar, Verena Pichler, Markus Mitterhauser, Marcus Hacker
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
IntroductionInhibitors of sodium-glucose linked transporter-2 (SGLT2i) are enhancing glucose excretion in the proximal renal tubules, and thus are increasingly used to lower blood glucose levels in patients with type 2 diabetes mellitus (T2DM). The g
Externí odkaz:
https://doaj.org/article/d6c1649dea9a409cb2bce21b0e5b8ec9
Autor:
Barbara Katharina Geist, Helmut Brath, Lucia Zisser, Josef Yu, Barbara Fueger, Lukas Nics, Eva Maria Patronas, Alexandra Kautzky-Willer, Marcus Hacker, Sazan Rasul
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging.
Purpose Sodium-glucose cotransporter 2 inhibitor (SGLT2i) regulation, developed as treatment for patients with type 2 diabetes, can be imaged with the glucose analogue alpha-methyl-4-deoxy-4-[18F]fluoro-d-glucopyranoside (Me4FDG), a positron emission
Autor:
Magdalena Bastian, Helmut Brath, Ivica Just, Martin Krššák, Jürgen Harreiter, Alexandra Kautzky-Willer, Michael Leutner, Christian Schelkshorn, Radka Klepochová
Publikováno v:
Diabetes, Obesity and Metabolism. 23:1129-1139
AIMS To investigate the potential synergistic effects of combined exenatide (EXE) and dapagliflozin (DAPA) versus (PLAC) placebo and DAPA on hepatocellular lipid (HCL) reduction after 24 weeks of treatment. MATERIALS AND METHODS Thirty patients with
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0150553 (2016)
We aimed to investigate the prevalence and correlates of smoking in people living with HIV (PLWHIV) in Germany and Austria and their readiness to quit. A total of 447 consecutive patients with confirmed positive HIV status who were treated in differe
Externí odkaz:
https://doaj.org/article/884f24aae9f34da091227248140443c3
Autor:
Annemarie Grindel, Bianca Guggenberger, Lukas Eichberger, Christina Pöppelmeyer, Michaela Gschaider, Anela Tosevska, George Mare, David Briskey, Helmut Brath, Karl-Heinz Wagner
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162082 (2016)
BACKGROUND:Diabetes mellitus type 2 (T2DM) is associated with oxidative stress which in turn can lead to DNA damage. The aim of the present study was to analyze oxidative stress, DNA damage and DNA repair in regard to hyperglycemic state and diabetes
Externí odkaz:
https://doaj.org/article/1099534366f9470385acc070943c385d
Autor:
Peter Siostrzonek, Helmut Brath, Robert Zweiker, Heinz Drexel, Robert Hoelzl, Margit Hemetsberger, Kausik K. Ray
Publikováno v:
Wiener klinische Wochenschrift. 134(7-8)
Summary Background Cardiovascular disease (CVD) is the most frequent cause of death in Austria. The European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines recommend intensive lipid lowering therapy (LLT) in patients at